Bolognini Daniele, Dedeo Domonkos, Milligan Graeme
Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, United Kingdom.
Curr Opin Endocr Metab Res. 2021 Feb;16:1-9. doi: 10.1016/j.coemr.2020.06.005. Epub 2020 Jul 3.
FFA2 and FFA3 are receptors for short-chain fatty acids which are produced in prodigious amounts by fermentation of poorly digested carbohydrates by gut bacteria. Understanding the roles of these receptors in regulating enteroendocrine, metabolic and immune functions has developed with the production and use of novel pharmacological tools and animal models. A complex (patho)physiological scenario is now emerging in which strategic expression of FFA2 and FFA3 in key cell types and selective modulation of their signalling might regulate body weight management, energy homoeostasis and inflammatory disorders.
游离脂肪酸受体2(FFA2)和游离脂肪酸受体3(FFA3)是短链脂肪酸的受体,肠道细菌对消化不完全的碳水化合物进行发酵会大量产生短链脂肪酸。随着新型药理学工具和动物模型的产生与应用,人们对这些受体在调节肠内分泌、代谢和免疫功能方面的作用有了进一步了解。目前正在出现一种复杂的(病理)生理情况,即FFA2和FFA3在关键细胞类型中的策略性表达及其信号传导的选择性调节可能会对体重管理、能量稳态和炎症性疾病产生影响。
Curr Opin Endocr Metab Res. 2021-2
J Physiol. 2015-2-1
Neurogastroenterol Motil. 2018-8-23
Eur J Pharmacol. 2021-9-5
Handb Exp Pharmacol. 2017
Trends Pharmacol Sci. 2021-3
Front Cell Infect Microbiol. 2023
Medicine (Baltimore). 2023-12-15
Nutrients. 2023-8-25
J Med Chem. 2023-5-11
Biochim Biophys Acta Mol Cell Res. 2020-2-21
Am J Physiol Regul Integr Comp Physiol. 2020-2-19